Penumbra, Inc. to Present at Citi's 2022 Virtual Healthcare Conference
Get Alerts PEN Hot Sheet
Join SI Premium – FREE
ALAMEDA, Calif., Feb. 10, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at Citi's 2022 Virtual Healthcare Conference on Thursday, February 24, 2022.
Event: Citi's 2022 Virtual Healthcare ConferenceDate: Thursday, February 24, 2022Time: 1:15pm ET / 10:15am PT
A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc. 510-995-2461 [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-citis-2022-virtual-healthcare-conference-301478010.html
SOURCE Penumbra, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BC Platforms launches BC Mosaic App Store to empower data scientists and healthcare researchers with innovative analytics and workflow applications
- Wolters Kluwer collaborates with Finago to connect financial workflows for accounting firms and businesses in Sweden
- Performance Brokerage Services Advises on the Sale of Brown's RV Superstore in McBee, South Carolina from the Brown Family to Blue Compass RV
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Citi, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share